NEFH and amyotrophic lateral sclerosis: Higher CSF p‐NfH and NfL levels were observed in ALS patients with fast progression rate compared to those with intermediate (P = .0149 for p‐NfH) and slow progression rate (P < .0001 for both p‐NfH and NfL) (Figure 1C, D).